Novelix Pharmaceuticals Ltd — Important, 16-10-2025: Company Update
16-10-2025 | 08:04 pm
16-10-2025 | 08:04 pm
Novelix Pharmaceuticals has entered a technology transfer agreement with Germany's GMBU e.V. for the large-scale production of Astaxanthin. This collaboration will enable Novelix to cultivate and scale up Astaxanthin, a potent antioxidant with significant nutraceutical and pharmaceutical applications, at its Hyderabad facilities. Novelix plans to establish a GMP-certified production plant to target key markets including Europe, North America, and India, enhancing its product portfolio and global supply capabilities in high-value biotech ingredients.
No comments yet. Be the first to comment!
